Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-β1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1385-1394

  Gordon, Erlinda M ^a   Skotzko, Michael ^a   Kundu, Ramendra Krishna ^a   Han, Bo ^a   Andrades, Jose ^a   Nimni, Marcel ^a   Anderson, W French ^a   Hall, Frederick L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; COLLAGEN; HYBRID PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VECTOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; FIBROBLAST; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; MESENCHYME; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STROMA CELL; TRANSGENE;

ANIMALIA; BLASTOIDEA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0030839589     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1385     Document Type: Article

References (41)

1. ANDRADES, J.A., NIMNI, M.E., HAN, B., ERTL, D.C., HALL, F.L., and BECERRA, J. (1996). Type I collagen combined with a rcombinant TGF-β serves as a scaffold for mesenchymal stem cells. Int. J. Dev. Biol. 1, 107-108.
2. 1 induces bone closure of skull defects. J. Bone Mineral Res. 6, 1257-1265.
3. BENYA, P. (1981). Two-dimensional CNBr peptide patterns of collagen types I, II and III. Collagen Res. 1, 17-26.
4. BERARDI, A.C., WANG, A., LEVINE, J.D., LOPEZ, P., and SCADDEN, D.T. (1995). Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104-108.
5. BRUDER, S.P., FINK, D., and CAPLAN, A.I. (1994). Mesenchymal stem cells in bone development, bone repair and skeletal regeneration therapy. J. Cell Biochem. 56, 283-294.
6. CAPLAN, A.I. (1991). Mesenchymal stem cells. J. Orthopaedic Res. 9, 641-650.
7. CENTRELLA, M., HOROWITZ, M.C., WOZNEY, J.M., and McCARTHY, T.L. (1994). Transforming growth factor-β gene family members and bone. Endocr. Rev. 15, 27-39.
8. CHORCZYNSKI, P., and SACCHI, N. (1988). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extration. Anal. Biochem. 192, 156-159.
9. DENNIS, J.E., and CAPLAN, A.I. (1993). Porous ceramic vehicles for rat-marrow-derived (Rattus Norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin. J. Oral Implant, 19, 106-137.
10. DERYNK, R. (1994). Transforming growth factor β. In The Cytokine Handbook, 2nd ed. A. Thompson, ed. (Academic Press, New York) pp. 319-342.
11. DIXON, W.J., BROWN, M.D., and ENGELMAN, L. (1990). BMDP Statistical Software. University of California Press, Berkeley.
12. GAZIT, D., EBNER, R., KAHN, A.J., and DERYNCK, R. (1993). Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol. Endocrinol. 7, 189-198.
13. GORDON, E.M., TANG, H., SALAZAR, R.L., and KOHN, D.B. (1993). Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer. Amer. J. Pediatr. Hematol. Oncol 15, 195-203.
14. GORDON, E.M., D'ALISA, R., TANG, H., SALAZAR, R., SABATINO, R.D., DORIO, R., KOHN, D.B., and HOLT, J. (1995). Characterization of monoclonal antibody-purified factor IX produced in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer. J. Int. Pediatr. Hematol. Oncol. 2, 185-191.
15. HASEGAWA, T., OGUCHI, H., MIZUNO, M., and KUBOKI, Y. (1994). Jpn. J. Oral Biol. 36, 383-394.
16. HAYNESWORTH, S.E., GOSHIMA, J., GOLDBERG, V.M., and CAPLAN, A.I. (1992a). Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.
17. HAYNESWORTH, E.W., BABER, A.M., and CAPLAN, A.I. (1992b). Cell surface antigens of human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69-80.
18. JOYCE, M.E., ROBERTS, A.B., SPORN, M.B., and BOLANDER, M.E. (1990). Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110, 2195-2207.
19. KELLER, J.R., SING, G.K., ELLINGSWORTH, L.R., and RUSCETTI, F.W. (1989). Transforming growth factor-beat 1 enhances the sippression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha. J. Cell. Biochem. 39, 175-184.
20. KELLER, J.R., MUNIECE, I.K., SILL, K.T., ELLINGSWORTH, L.R., QUESENBERRY, P.J., SING, G.K., and RUSCETTI, F.W. (1990). Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood 75, 596-602.
21. LONG, M.W., ROBINSON, J.A., ASHCRAFT, E.A., and MANN, K.G. (1995). Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J. Clin. Invest. 95, 881-887.
22. LUCAS, C., WALLICK, S., FENDLY, B.M., FIGARI, I., and PALLADINO, M.A. (1991). TGF-β: a possible autocrine immune regulator. In Clinical application of TGF-beta. Ciba Found. Symp. 157. G. Bock and J. Marsh, eds. (John Wiley and Sons, NY) p. 98-108.
23. MIZUNO, M., and KUBKI, Y. (1995). TGF-beta accelerated the osteogenic differentiation of bone marrow cells induced by collagen matrix. Biochem. Biophysic. Res. Commun. 211, 1091-1098.
24. NIMNI, M.E. (1980). The molecular organization of collagen and its role in determining the biophysical properties of the connective tissues. Biorheology 17, 51-82.
25. NIMNI, M.E., CHEUNG, D., STRATES, KODAMA, M., and SHEIKH, K. (1987). Chemically modified collagen: a natural biomaterial for tissue replacement. J. Biomed. Mater. Res. 21, 741-771.
26. OWEN, M. (1985). Lineage of osteogenic cells and their relationship to the stromal system. In Bone Mineral Research. W.A. Peck, ed. (Elsevier Science Publishers B.V. 3) pp. 1-25.
27. PALMER, T.D., THOMPSON, A.R., and MILLER, A.D. (1989). Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73, 438-445.
28. ROBERTS, A.B., and SPORN, M.B. (1990). Transforming growth factor-βs. In Peptide Growth Factors and Their Receptors. A.B. Roberts and M.B. Sporn, eds. (Springer Verlag, Heidelberg, Germany) pp. 419-472.
29. ROBERTS, A.B., and SPORN, M.B. (1993). Physiological actions and clinical applications of transforming growth factor-beta (TGF-β). Growth Factors 8, 1-9.
30. ROBERTS, H.R., and LOZIER, J.N. (1995). Clinical aspects and therapy for hemophilia B. In Hematology Basic Principles and Practice R. Hoffman, E.J. Benz, S.J. Shattil, B. Furie, H.J. Cohen, eds. (Churchill Livingstone, New York) p. 1325.
31. ROMAN, M., AXELROD, J.H., DAI, Y., NAVIAUX, R.K., FRIEDMAN, T., and VERMA, I.M. (1992). Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat. Cell. Mol. Genet. 18, 247-258.
32. SKOTZKO, M.J., WU, L.T., ANDERSON, W.F., GORDON, E.M., and HALL, F.L. (1995). Retroviral vector-mediated gene transfer of antisense cyclic G1 (CTCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res. 55, 5493-5498.
33. TANIGUCHI, Y., TANAKA, K., GOTOH, K., SATOH, R., and INAZU, M. (1993). Transforming growth factor β1-induced cellular heterogeneity in the periosteum of rat parietal bones. Calcif. Tissue Int. 53, 122-126.
34. THOMPSON, A.R. (1991). Molecular biology of the hemophilias. Prog. Hemost. Thromb. 10, 174-214.
35. TRECO, D.A., HEARTLEIN, M.W., and SELDEN, R.F. (1995). Fibroblast cell biology and gene therapy. In Somatic Gene Therapy. P.L. Chang, ed. (CRC Press, New York) pp. 54-59.
36. TUAN, T.L., CHEUNG, D.T., WU, L.T., YEE, A., GABRIEL, S., HAN, B., MORTON, L., NIMNI, M.E., and HALL, F.L. (1996). Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Conn. Tiss. Res. 34, 1-9.
37. WRANN, M., BODMER, S., DE MARTIN, R., SIEPL, C., HOFER-WARBINEK, R., FREI, K., HOEFER, E., and FONTANA, A. (1987). To cell suppressor factor from human glioblastoma cells is a 12.5 KD protein closely relating to transforming growth factor-bete. EMBO. J. 6, 1633-1636.
38. YAO, S.N., DE SILVA, A.H., KURACHI, S., SAMUELSON, L.C., and KURACHI, K. (1991a). Characterization of a mouse factor IX cDNA and developmental regulation of the factor IX gene expression in liver. Thrombos. Hemostas. 65, 52-58.
39. YAO, S.N., WILSON, J.M., NABEL, E.G., KURACHI, S., HACHIYA, H.L., and KURACHI, K. (1991b). Expression of human factor IX in rat capillary endothelial cells: towards somatic gene therapy for hemophilia B. Proc. Natl. Acad. Sci. USA 88, 8101-8105.
40. YAO, S.N., and KURACHI, K. (1992). Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. USA 89, 3357-3361.
41. YOUNG, H.E., CEBALLOS, E.M., SMITH, J.C., MANCINI, M.L., WRIGHT, R.P., RAGAN, B.L., BUSHELL, I., and LUCAS, P.A. (1993). Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell Dev. Biol. 29A, 723-736.